News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
508,649 Results
Type
Article (29121)
Company Profile (145)
Press Release (479383)
Multimedia
Podcasts (73)
Webinars (14)
Section
Business (148940)
Career Advice (1621)
Deals (28237)
Drug Delivery (93)
Drug Development (66074)
Employer Resources (126)
FDA (12011)
Job Trends (11368)
News (260913)
Policy (25280)
Tag
Academia (1911)
Academic (1)
Accelerated approval (6)
Adcomms (16)
Allergies (80)
Alliances (38716)
ALS (96)
Alzheimer's disease (1077)
Antibody-drug conjugate (ADC) (123)
Approvals (12074)
Artificial intelligence (246)
Autoimmune disease (25)
Automation (13)
Bankruptcy (260)
Best Places to Work (8826)
BIOSECURE Act (21)
Biosimilars (94)
Biotechnology (68)
Bladder cancer (78)
Brain cancer (32)
Breast cancer (280)
Cancer (2306)
Cardiovascular disease (187)
Career advice (1336)
Career pathing (25)
CAR-T (157)
CDC (22)
Cell therapy (401)
Cervical cancer (21)
Clinical research (55403)
Collaboration (797)
Compensation (314)
Complete response letters (23)
COVID-19 (2060)
CRISPR (50)
C-suite (263)
Cystic fibrosis (83)
Data (2544)
Denatured (20)
Depression (51)
Diabetes (271)
Diagnostics (4372)
Digital health (14)
Diversity (5)
Diversity, equity & inclusion (34)
Drug discovery (114)
Drug pricing (112)
Drug shortages (32)
Duchenne muscular dystrophy (110)
Earnings (59081)
Editorial (32)
Employer branding (11)
Employer resources (112)
Events (72841)
Executive appointments (697)
FDA (13438)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (707)
Gene editing (107)
Generative AI (20)
Gene therapy (303)
GLP-1 (661)
Government (3501)
Grass and pollen (5)
Guidances (169)
Healthcare (13019)
HIV (36)
Huntington's disease (15)
IgA nephropathy (42)
Immunology and inflammation (120)
Immuno-oncology (8)
Indications (37)
Infectious disease (2189)
Inflammatory bowel disease (124)
Inflation Reduction Act (8)
Influenza (47)
Intellectual property (101)
Interviews (249)
IPO (12621)
IRA (43)
Job creations (2897)
Job search strategy (1180)
Kidney cancer (11)
Labor market (35)
Layoffs (386)
Leadership (15)
Legal (5532)
Liver cancer (63)
Longevity (8)
Lung cancer (327)
Lymphoma (177)
Machine learning (7)
Management (48)
Manufacturing (327)
MASH (83)
Medical device (8113)
Medtech (8117)
Mergers & acquisitions (16248)
Metabolic disorders (686)
Multiple sclerosis (84)
NASH (20)
Neurodegenerative disease (82)
Neuropsychiatric disorders (18)
Neuroscience (1629)
NextGen: Class of 2025 (4519)
Non-profit (3344)
Now hiring (25)
Obesity (345)
Opinion (203)
Ovarian cancer (92)
Pain (101)
Pancreatic cancer (99)
Parkinson's disease (149)
Partnered (17)
Patents (256)
Patient recruitment (137)
Peanut (37)
People (44767)
Pharmaceutical (72)
Pharmacy benefit managers (20)
Phase I (16469)
Phase II (24330)
Phase III (19162)
Pipeline (1467)
Policy (177)
Postmarket research (1973)
Preclinical (6595)
Press Release (67)
Prostate cancer (110)
Psychedelics (29)
Radiopharmaceuticals (204)
Rare diseases (391)
Real estate (4416)
Recruiting (49)
Regulatory (18344)
Reports (32)
Research institute (1724)
Resumes & cover letters (271)
Rett syndrome (8)
RNA editing (6)
RSV (36)
Schizophrenia (77)
Series A (132)
Series B (82)
Service/supplier (7)
Sickle cell disease (60)
Special edition (10)
Spinal muscular atrophy (119)
Sponsored (30)
Startups (2724)
State (2)
Stomach cancer (14)
Supply chain (59)
Tariffs (52)
The Weekly (51)
Vaccines (570)
Venture capital (41)
Weight loss (214)
Women's health (27)
Worklife (14)
Date
Today (16)
Last 7 days (267)
Last 30 days (1341)
Last 365 days (24228)
2025 (13215)
2024 (27349)
2023 (30915)
2022 (40190)
2021 (42672)
2020 (41618)
2019 (34130)
2018 (25950)
2017 (25163)
2016 (23784)
2015 (28195)
2014 (21217)
2013 (17412)
2012 (18623)
2011 (19493)
2010 (17430)
Location
Africa (608)
Alabama (36)
Alaska (6)
Arizona (128)
Arkansas (8)
Asia (38067)
Australia (6450)
California (5409)
Canada (1911)
China (715)
Colorado (244)
Connecticut (250)
Delaware (140)
Europe (71285)
Florida (858)
Georgia (175)
Hawaii (1)
Idaho (31)
Illinois (479)
India (27)
Indiana (272)
Iowa (4)
Japan (209)
Kansas (82)
Kentucky (24)
Louisiana (13)
Maine (48)
Maryland (854)
Massachusetts (4104)
Michigan (143)
Minnesota (291)
Mississippi (1)
Missouri (69)
Montana (17)
Nebraska (19)
Nevada (70)
New Hampshire (50)
New Jersey (1799)
New Mexico (17)
New York (1657)
North Carolina (812)
North Dakota (3)
Northern California (2361)
Ohio (155)
Oklahoma (9)
Oregon (25)
Pennsylvania (1228)
Puerto Rico (15)
Rhode Island (18)
South America (894)
South Carolina (28)
Southern California (2093)
Tennessee (99)
Texas (835)
United States (20764)
Utah (134)
Virginia (169)
Washington D.C. (58)
Washington State (509)
West Virginia (4)
Wisconsin (45)
508,649 Results for "china resources pharmaceutical group limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Brii Biosciences Announces Licensing Agreement with Joincare Group for Rights to BRII-693 in Greater China
July 4, 2025
·
5 min read
Press Releases
HELP Therapeutics and China Resources Sanjiu Announce Strategic Partnership to Co-Develop and Commercialize HiCM-188 for Advanced Heart Failure in Mainland China
June 16, 2025
·
2 min read
Antibody-drug conjugate (ADC)
NextCure Joins China-ADC Gold Rush with $745M Simcere Deal
The deal gets NextCure the rights to Simcere’s novel ADC for solid tumors outside of China.
June 16, 2025
·
1 min read
·
Dan Samorodnitsky
Artificial intelligence
AstraZeneca Makes $5.3B AI Bet With China’s CSPC for Chronic Disease Pills
Friday’s deal with CSPC fits neatly within AstraZeneca’s business development strategy of upping investments in AI and in China.
June 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
HELP Therapeutics and China Resources Sanjiu Announce Strategic Partnership to Co-Develop and Commercialize HiCM-188 for Advanced Heart Failure
June 16, 2025
·
2 min read
Government
FDA Freezes Trials Shipping Cells to China, ‘Other Hostile Countries’
Exemptions to new export control policies have allowed companies to ship patients’ biological materials to foreign laboratories, including those in China and other adversarial nations, according to the FDA.
June 20, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Connect Biopharma’s Exclusive Licensee in China, Simcere Pharmaceutical, Announced Submission of its New Drug Application for Rademikibart for the Treatment of Atopic Dermatitis in China
July 10, 2025
·
7 min read
Qilian International Holding Group Limited Announces 1 for 5 Reverse Share Split
Qilian International Holding Group Limited, a China-based pharmaceutical and chemical products manufacturer, announced that an 1 for 5 reverse split of its authorized share capital, was approved by the Company’s board of directors on May 29, 2023 and will become effective on June 21, 2024.
June 18, 2024
·
4 min read
Legal
Medical Groups Sue RFK Jr. Over ‘Baseless and Uninformed’ Changes to COVID-19 Vaccine Policy
Societies, including the American Academy of Pediatrics, allege that Kennedy’s directive to remove COVID-19 from vaccination guidelines for healthy pregnant women and healthy children puts these vulnerable groups at risk of serious illness.
July 8, 2025
·
2 min read
·
Tristan Manalac
Tariffs
China Still Go-To Source for New Drugs Despite Tariff Minefield
Policy uncertainties are impacting biopharma dealmaking from continent to continent, with companies being asked to walk a tightrope on their relations with China.
April 30, 2025
·
10 min read
·
Annalee Armstrong
1 of 50,865
Next
